For research use only. We do not sell to patients.
CD73-IN-3
CAS No. : 2375815-63-5
Biological Activity：CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research.
Research Area：Cancer
Targets：CD73
Related Screening Libraries:Bioactive Compound Library Plus;Immunology/Inflammation Compound Library;Anti-Cancer Compound Library;Small Molecule Immuno-Oncology Compound Library;
Related Small Molecules:PSB-12379;CD73-IN-7;AB-680 ammonium;CD73-IN-6;OP-5244 sodium;CD73-IN-12;Uliledlimab;CD73-IN-4;ZM514;CD73-IN-1;CD73-IN-9;MRS4620;CD73-IN-8;Oleclumab;CD73-IN-13;CD73-IN-10;CD73-IN-5;CD73-IN-2;Mupadolimab;CD73-IN-11
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
